Study to Assess Xevinapant in Preoperative Subjects With Recurrent High-Grade Glioma (rHGG)
Clinical trial NCT06463184 · WITHDRAWN
Trial details
- NCT number
- NCT06463184
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-22
- Primary completion
- 2027-06-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.